ARTICLE | Financial News
Cel-Sci completes direct public offering
March 10, 2017 7:58 PM UTC
Cancer and infectious disease company Cel-Sci Corp. (NYSE-M:CVM) raised $1.5 million through the sale of 15 million shares at $0.10 in a registered direct offering to institutional investors on March...
BCIQ Company Profiles